Perfil
Mike Blaire is currently working as an Executive Advisor at h LLC.
Prior to this, he worked as the CEO of Diamondback Drugs LLC from 2001 to 2017 and as the CEO of Mrb Pharmacies, Inc. from 1981 to 1993.
He completed his undergraduate degree from the University of Rochester in 1980, a graduate degree from Arizona State University in 1998, and another undergraduate degree from St. John's University in 1983.
Cargos activos de Mike Blaire
| Empresas | Cargo | Inicio |
|---|---|---|
SHERIDAN CP LP
SHERIDAN CP LP Investment ManagersFinance Sheridan CP invests in lower middle market companies located in the United States and Canada with an EBITDA of USD 5 to 25 million. The firm focuses on healthcare and consumer. It participates in buyout and recapitalizations transactions with an investment between USD 30 to 150 million and also acquires control position. | Consultor / Asesor | - |
Antiguos cargos conocidos de Mike Blaire.
| Empresas | Cargo | Fin |
|---|---|---|
Diamondback Drugs LLC
Diamondback Drugs LLC Agricultural Commodities/MillingProcess Industries Provides veterinary medical services | Director Ejecutivo | 30/05/2017 |
Mrb Pharmacies, Inc. | Director Ejecutivo | 31/03/1993 |
Formación de Mike Blaire.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Rochester Christian University
Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arizona State University
Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. John's University
St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SHERIDAN CP LP
SHERIDAN CP LP Investment ManagersFinance Sheridan CP invests in lower middle market companies located in the United States and Canada with an EBITDA of USD 5 to 25 million. The firm focuses on healthcare and consumer. It participates in buyout and recapitalizations transactions with an investment between USD 30 to 150 million and also acquires control position. | Finance |
Diamondback Drugs LLC
Diamondback Drugs LLC Agricultural Commodities/MillingProcess Industries Provides veterinary medical services | Process Industries |
Mrb Pharmacies, Inc. |
- Bolsa de valores
- Insiders
- Mike Blaire
















